Literature DB >> 28697414

Analytical methodologies for broad metabolite coverage of exhaled breath condensate.

Alexander A Aksenov1, Konstantin O Zamuruyev1, Alberto Pasamontes1, Joshua F Brown1, Michael Schivo2, Soraya Foutouhi3, Bart C Weimer3, Nicholas J Kenyon2, Cristina E Davis4.   

Abstract

Breath analysis has been gaining popularity as a non-invasive technique that is amenable to a broad range of medical uses. One of the persistent problems hampering the wide application of the breath analysis method is measurement variability of metabolite abundances stemming from differences in both sampling and analysis methodologies used in various studies. Mass spectrometry has been a method of choice for comprehensive metabolomic analysis. For the first time in the present study, we juxtapose the most commonly employed mass spectrometry-based analysis methodologies and directly compare the resultant coverages of detected compounds in exhaled breath condensate in order to guide methodology choices for exhaled breath condensate analysis studies. Four methods were explored to broaden the range of measured compounds across both the volatile and non-volatile domain. Liquid phase sampling with polyacrylate Solid-Phase MicroExtraction fiber, liquid phase extraction with a polydimethylsiloxane patch, and headspace sampling using Carboxen/Polydimethylsiloxane Solid-Phase MicroExtraction (SPME) followed by gas chromatography mass spectrometry were tested for the analysis of volatile fraction. Hydrophilic interaction liquid chromatography and reversed-phase chromatography high performance liquid chromatography mass spectrometry were used for analysis of non-volatile fraction. We found that liquid phase breath condensate extraction was notably superior compared to headspace extraction and differences in employed sorbents manifested altered metabolite coverages. The most pronounced effect was substantially enhanced metabolite capture for larger, higher-boiling compounds using polyacrylate SPME liquid phase sampling. The analysis of the non-volatile fraction of breath condensate by hydrophilic and reverse phase high performance liquid chromatography mass spectrometry indicated orthogonal metabolite coverage by these chromatography modes. We found that the metabolite coverage could be enhanced significantly with the use of organic solvent as a device rinse after breath sampling to collect the non-aqueous fraction as opposed to neat breath condensate sample. Here, we show the detected ranges of compounds in each case and provide a practical guide for methodology selection for optimal detection of specific compounds.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Exhaled breath condensate (EBC); Gas chromatography mass spectrometry (GC/MS); High performance liquid chromatography mass spectrometry (HPLC/MS); Hydrophilic interaction liquid chromatography (HILIC); Metabolites; Reversed-phase liquid chromatography (RP)

Mesh:

Substances:

Year:  2017        PMID: 28697414      PMCID: PMC5573623          DOI: 10.1016/j.jchromb.2017.06.038

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  38 in total

Review 1.  Technology development in breath microanalysis for clinical diagnosis.

Authors:  W H Cheng; W J Lee
Journal:  J Lab Clin Med       Date:  1999-03

2.  Protein pattern of exhaled breath condensate and saliva.

Authors:  Matthias Griese; Jochen Noss; Christina von Bredow
Journal:  Proteomics       Date:  2002-06       Impact factor: 3.984

3.  Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS.

Authors:  Scott A Gerber; John Rush; Olaf Stemman; Marc W Kirschner; Steven P Gygi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-27       Impact factor: 11.205

4.  Exhaled breath condensate: methodological recommendations and unresolved questions.

Authors:  I Horváth; J Hunt; P J Barnes; K Alving; A Antczak; E Baraldi; G Becher; W J C van Beurden; M Corradi; R Dekhuijzen; R A Dweik; T Dwyer; R Effros; S Erzurum; B Gaston; C Gessner; A Greening; L P Ho; J Hohlfeld; Q Jöbsis; D Laskowski; S Loukides; D Marlin; P Montuschi; A C Olin; A E Redington; P Reinhold; E L J van Rensen; I Rubinstein; P Silkoff; K Toren; G Vass; C Vogelberg; H Wirtz
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

5.  Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate.

Authors:  P P Rosias; C M Robroeks; H J Niemarkt; A D Kester; J H Vernooy; J Suykerbuyk; J Teunissen; J Heynens; H J Hendriks; Q Jöbsis; E Dompeling
Journal:  Eur Respir J       Date:  2006-07-26       Impact factor: 16.671

6.  The suitability of Tedlar bags for breath sampling in medical diagnostic research.

Authors:  Marco M L Steeghs; Simona M Cristescu; Frans J M Harren
Journal:  Physiol Meas       Date:  2006-11-24       Impact factor: 2.833

7.  Endogenous Levels of Five Fatty Acid Metabolites in Exhaled Breath Condensate to Monitor Asthma by High-Performance Liquid Chromatography: Electrospray Tandem Mass Spectrometry.

Authors:  Malin L Nording; Jun Yang; Christine M Hegedus; Abhinav Bhushan; Nicholas J Kenyon; Cristina E Davis; Bruce D Hammock
Journal:  IEEE Sens J       Date:  2010-01-01       Impact factor: 3.301

8.  Novel noninvasive identification of biomarkers by analytical profiling of chronic wounds using volatile organic compounds.

Authors:  Alexis N Thomas; Svetlana Riazanskaia; William Cheung; Yun Xu; Royston Goodacre; C L Paul Thomas; Mohamed S Baguneid; Ardeshir Bayat
Journal:  Wound Repair Regen       Date:  2010-05-11       Impact factor: 3.617

9.  Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry.

Authors:  Magdalena Ligor; Tomasz Ligor; Amel Bajtarevic; Clemens Ager; Martin Pienz; Martin Klieber; Hubert Denz; Michael Fiegl; Wolfgang Hilbe; Wolfgang Weiss; Peter Lukas; Herbert Jamnig; Martin Hackl; Boguslaw Buszewski; Wolfram Miekisch; Jochen Schubert; Anton Amann
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

10.  Prediction of lung cancer using volatile biomarkers in breath.

Authors:  Michael Phillips; Nasser Altorki; John H M Austin; Robert B Cameron; Renee N Cataneo; Joel Greenberg; Robert Kloss; Roger A Maxfield; Muhammad I Munawar; Harvey I Pass; Asif Rashid; William N Rom; Peter Schmitt
Journal:  Cancer Biomark       Date:  2007       Impact factor: 4.388

View more
  5 in total

1.  Power-efficient self-cleaning hydrophilic condenser surface for portable exhaled breath condensate (EBC) metabolomic sampling.

Authors:  Konstantin O Zamuruyev; Alexander J Schmidt; Eva Borras; Mitchell M McCartney; Michael Schivo; Nicholas J Kenyon; Jean-Pierre Delplanque; Cristina E Davis
Journal:  J Breath Res       Date:  2018-06-08       Impact factor: 3.262

2.  Effect of temperature control on the metabolite content in exhaled breath condensate.

Authors:  Konstantin O Zamuruyev; Eva Borras; Dayna R Pettit; Alexander A Aksenov; Jason D Simmons; Bart C Weimer; Michael Schivo; Nicholas J Kenyon; Jean-Pierre Delplanque; Cristina E Davis
Journal:  Anal Chim Acta       Date:  2017-12-30       Impact factor: 6.558

3.  Exhaled breath biomarkers of influenza infection and influenza vaccination.

Authors:  Eva Borras; Mitchell M McCartney; Cai H Thompson; Robert J Meagher; Nicholas J Kenyon; Michael Schivo; Cristina E Davis
Journal:  J Breath Res       Date:  2021-08-19       Impact factor: 4.538

4.  Novel LC-MS-TOF method to detect and quantify ascorbic and uric acid simultaneously in different biological matrices.

Authors:  Eva Borras; Leah Schrumpf; Noelle Stephens; Bart C Weimer; Cristina E Davis; Edward S Schelegle
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2021-02-16       Impact factor: 3.318

5.  Investigating the relationship between breath aerosol size and exhaled breath condensate (EBC) metabolomic content.

Authors:  Alexander J Schmidt; Eva Borras; Nicholas J Kenyon; Cristina E Davis
Journal:  J Breath Res       Date:  2020-10-06       Impact factor: 3.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.